W. S. Jones

Peripheral Vascular Disease : Pipeline and Trial Designs : An Evaluation of the ClinicalTrials . gov Database

A. Tasneem, S. Subherwal, John R. Laird, 2014 .

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

H. Huikuri, H. Suryapranata, A. Bagai, 2024, European heart journal. Cardiovascular pharmacotherapy.